Active, Not Recruiting
A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA
NCT05601232
- Conditions
- Unresectable Angiosarcoma
- Locations
-
- National Cancer Center Hospital Tokyo, Japan